Xenetic Biosciences, Inc. (XBIO) on Tuesday reported a loss of $903,000 in its first quarter. The Framingham, Massachusetts-based company said it had a loss of 59 cents per share. The company posted ...

Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR ...